Electromed, Inc. (NYSE:ELMD) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC lessened its stake in Electromed, Inc. (NYSE:ELMD) by 2.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 67,874 shares of the company’s stock after selling 1,953 shares during the quarter. Geode Capital Management LLC’s holdings in Electromed were worth $1,458,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of ELMD. Barclays PLC bought a new stake in Electromed in the third quarter valued at about $215,000. Walleye Capital LLC bought a new position in Electromed during the 3rd quarter worth approximately $274,000. Marshall Wace LLP acquired a new position in shares of Electromed in the 2nd quarter worth approximately $256,000. Navellier & Associates Inc. bought a new stake in shares of Electromed in the 3rd quarter valued at approximately $368,000. Finally, State Street Corp raised its position in shares of Electromed by 14.5% during the 3rd quarter. State Street Corp now owns 22,066 shares of the company’s stock valued at $474,000 after acquiring an additional 2,800 shares in the last quarter. Institutional investors own 40.82% of the company’s stock.

Insiders Place Their Bets

In other news, Director Andrew Summers sold 12,731 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $29.98, for a total transaction of $381,675.38. Following the completion of the transaction, the director now directly owns 165,755 shares of the company’s stock, valued at approximately $4,969,334.90. This represents a 7.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.00% of the stock is currently owned by corporate insiders.

Electromed Price Performance

Shares of ELMD opened at $31.12 on Thursday. The stock has a market capitalization of $263.21 million, a PE ratio of 43.22 and a beta of 0.31. The business’s fifty day moving average price is $28.23 and its 200 day moving average price is $21.34. Electromed, Inc. has a 12-month low of $9.90 and a 12-month high of $31.88.

Electromed (NYSE:ELMD) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.13. Electromed had a net margin of 11.34% and a return on equity of 15.32%. The company had revenue of $14.67 million for the quarter.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.